Jonathan T. Edelson
Gründer bei Anterios, Inc.
Profil
Jonathan T.
Edelson is the founder.
He founded Aureon Biosciences, Inc. in 2001 and held the title of Chief Executive Officer.
He also founded Anterios, Inc. in 2006 and holds the titles of Chairman & President.
Dr. Edelson is also the founder of Medical Decision Resources, Inc. Dr. Edelson's current job(s) include being the Chairman, President & Chief Executive Officer at Eirion Therapeutics, Inc. since 2016 and a Venture Partner at ABV LLC.
Dr. Edelson's former job(s) include being the Chief Executive Officer at Physicians Online, Inc. in 1998 and a Venture Advisor at Elm Street Advisors LLC in 2007.
Dr. Edelson's education history includes a doctorate degree from The University of Chicago, an undergraduate degree from Yale University, and a doctorate degree from Pritzker School of Medicine.
Aktive Positionen von Jonathan T. Edelson
Unternehmen | Position | Beginn |
---|---|---|
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Private Equity Investor | - |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | Gründer | 30.03.2006 |
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | Vorstandsvorsitzender | 01.01.2016 |
Ehemalige bekannte Positionen von Jonathan T. Edelson
Unternehmen | Position | Ende |
---|---|---|
Elm Street Advisors LLC
Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Corporate Officer/Principal | 31.10.2007 |
Physicians Online, Inc.
Physicians Online, Inc. Internet Software/ServicesTechnology Services Physicians Online, Inc. provides patient-oriented medical information and moderated support to patients on-line. The company was founded by Christian Mayaud and is headquartered in Tarrytown, NY. | Corporate Officer/Principal | 31.12.1998 |
Medical Decision Resources, Inc. | Gründer | - |
Aureon Biosciences, Inc.
Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Gründer | - |
Ausbildung von Jonathan T. Edelson
The University of Chicago | Doctorate Degree |
Yale University | Undergraduate Degree |
Pritzker School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Aureon Biosciences, Inc.
Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
Anterios, Inc.
Anterios, Inc. Pharmaceuticals: MajorHealth Technology Anterios, Inc. develops botulinum-based products for medical dermatology and aesthetic medicine. Its products include ANT-1207 which treats hyperhidrosis, and AI-09 which is a novel injectable formulation for therapeutic indications. The company was founded by John Edelson and is headquartered in Madison, NJ. | Health Technology |
Physicians Online, Inc.
Physicians Online, Inc. Internet Software/ServicesTechnology Services Physicians Online, Inc. provides patient-oriented medical information and moderated support to patients on-line. The company was founded by Christian Mayaud and is headquartered in Tarrytown, NY. | Technology Services |
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Finance |
Elm Street Advisors LLC
Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut. | Finance |
Eirion Therapeutics, Inc.
Eirion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eirion Therapeutics, Inc. is a clinical stage biopharmaceutical company that is developing prescription products for aesthetic dermatology. The company is based in Woburn, MA. The company has a pipeline of products that focus on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. Eirion plans to pursue additional indications that address other major unmet clinical needs for physicians and their patients. The company was founded in 2016. Jonathan T. Edelson has been the CEO of the company since 2016. | Health Technology |
Medical Decision Resources, Inc. |